Price To Earnings Ratio -4.79 | Sector PE 59.59 |
PB Ratio 2.92 | Sector PB 8.75 |
EPS -157.61 | Dividend Yield 0.00 |
Today's Volume 232.440 K | 5 Day Avg. Volume 198.067 K |
PEG Ratio 0.00 | Market Cap. ₹ 2,920.00 Cr. |
Time | SOLARA | VS | Industry |
---|---|---|---|
1 Day | -7.31% | -3.22% | |
1 Week | 1.87% | -5.8% | |
1 Month | 1.9% | -4.68% | |
6 Months | 24.35% | 16.04% | |
1 Year | 24.35% | 50.81% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 760.01 | Bearish |
20 | 760.47 | Bearish |
30 | 755.13 | Bearish |
50 | 726.97 | Bullish |
100 | 633.88 | Bullish |
200 | 521.26 | Bullish |
Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |||||
---|---|---|---|---|---|---|---|---|---|
Operating Activities | 108.87 | 156.25 | -242.03 | 155.46 | |||||
Investing Activities | -3.51 | -81.14 | -242.85 | -106.30 | |||||
Financing Activities | -105.65 | -112.76 | 333.57 | 92.49 | |||||
Net Cash Flow | -0.29 | -37.65 | -151.31 | 141.65 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
Solara Active Pharma Sciences | -7.31 | 1.87 | 1.9 | 24.35 | 24.35 |
Alembic | -3.07 | -13.09 | -16.04 | -10 | -10 |
Aurobindo Pharma | -0.97 | -2.16 | -2.84 | 24.09 | 54.91 |
Fortis Healthcare | -2.55 | -5.38 | -3.01 | 23.62 | 74.56 |
Ajanta Pharmaceuticals | -6.64 | -11.6 | -5.55 | 30.65 | 61.04 |
Solara Active Pharma Sciences Limited is an Indian company offering a wide range of commercial active ingredients (APIs) and contract manufacturing services in over 70 countries. The company operates through the API segment. Its commercial and R&D products include Albendazole, Aprepitant (Antiemetic), artesunate, brivaracetam (antiepileptic), Bumetanide (Inj) (Loop Diuretic), Buspirone HCL (Anxiolytic), Cetirizine Dihydrochloride, Chlorpromazine Hydrochloride, Cinacalcet Sodium (Cinacalcet Hydrochloride). Anticonvulsants), Colchicine (Antigout Agent), Colesevelam Hydrochloride, Cycloserine (Anti-Tuberculosis Agent), Ethacrynic acid (Cardiovascular System Support Agent), Hydralazine Hydrochloride (Hypertensive Agent), Ibuprofen Sodium Dihydrate (Anti-Inflammatory Agent), Mesna (Antineoplastic Detoxifying Agent), Mirabegron (treatment of OAB), pentoxifylline, etc. The company cooperates with North American, European and Japanese pharmaceutical companies.